First Time Loading...

Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 159.67 USD 4.28% Market Closed
Updated: May 2, 2024

Krystal Biotech Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Krystal Biotech Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Krystal Biotech Inc
NASDAQ:KRYS
Cash from Financing Activities
$202.8m
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Krystal Biotech Inc's Cash from Financing Activities?
Cash from Financing Activities
202.8m USD

Based on the financial report for Dec 31, 2023, Krystal Biotech Inc's Cash from Financing Activities amounts to 202.8m USD.

What is Krystal Biotech Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
22%

Over the last year, the Cash from Financing Activities growth was 474%. The average annual Cash from Financing Activities growth rates for Krystal Biotech Inc have been 20% over the past three years , 22% over the past five years .